Introduction
============

In recent years, tissue engineering, which involves seeding cells and a three-dimensional (3D) biomaterial scaffold, has become a promising approach for treating bone defects.[@b1-ijn-13-5799],[@b2-ijn-13-5799] With developments in materials science, biomaterial scaffolds are becoming safer and more multifunctional. Numerous studies have addressed how to improve the bio-compatibility of biomaterials for seeding cell growth.[@b3-ijn-13-5799] However, biomaterial implants initiate interactions with the host tissue after implantation; this may exert a profound impact on the host immune response, which may in turn affect the healing and repair process.[@b4-ijn-13-5799],[@b5-ijn-13-5799] As such, the osteo-immunomodulatory properties of biomaterials play an important role in the outcomes of bone regeneration.[@b6-ijn-13-5799],[@b7-ijn-13-5799] The traditional design of bone biomaterials mainly focuses on accelerating the osteogenic differentiation of the seeding cells, but fails to take into account the osteo-immunomodulatory properties of the biomaterial. To date, only limited studies have focused on this issue.

Several types of host cells collaboratively and sequentially participate in immune responses against the scaffolds.[@b8-ijn-13-5799] Macrophages (including their precursors, monocytes) are the first line of defense against foreign biomaterials. The inflammatory cytokines secreted by macrophages have been traditionally considered as more detrimental than beneficial with respect to the settlement of biomaterials in the body. However, increasing evidence has shown that an appropriate immune response is necessary for mediating tissue-scaffold integration.[@b9-ijn-13-5799],[@b10-ijn-13-5799] Some studies have shown that the inflammatory cytokines interleukin (IL)-4, IL-10, and IL13 have an osteogenic effect on bone formation, while tumor necrosis factor alpha (TNF-α), IL-6, and IL-1 have the opposite effect.[@b11-ijn-13-5799] Furthermore, immune cells could enhance neovascularization by secreting pro-angiogenic factors, such as vascular endothelial growth factor (VEGF) and TNF-α.[@b12-ijn-13-5799] Therefore, a new strategy constituting a more physiologically relevant way of improving the performance of engineered tissues may involve utilizing the power of macrophages.[@b13-ijn-13-5799] However, few studies have investigated how the interactions between biomaterials and immune cells affect the subsequent osteogenesis and angiogenesis of seeding cells.

Graphene is a two-dimensional (2D) carbonaceous material that has been widely applied in many research fields due to its unique physical, chemical, and mechanical properties. Graphene oxide (GO) is a product of the oxidation and exfoliation of graphite. In recent years, researchers have shown that GO can promote the osteogenic differentiation of bone marrow mesenchymal stem cells (BMSCs); therefore, it is recognized as a potential novel biomaterial for bone regeneration.[@b14-ijn-13-5799],[@b15-ijn-13-5799] GO has been found to elicit an immunomodulatory response that can affect the macrophage phenotype.[@b16-ijn-13-5799] However, the osteo-immunomodulatory effects of GO on the osteogenic differentiation of BMSCs and angiogenic differentiation of endothelial cells (ECs) are largely unknown.

In this study, we evaluated the influence of GO on the response of macrophages, osteogenic differentiation of BMSCs, and angiogenic differentiation of human umbilical vein endothelial cells (HUVECs). We also further investigated the possible mechanisms underlying the osteo- and angio-immunomodulatory effects of GO.

Materials and methods
=====================

Fabrication of GO nanocomposites
--------------------------------

GO powder was purchased from Tanfeng Tech (Suzhou, China). It was synthesized using a modified Hummer's method.[@b17-ijn-13-5799] Briefly, 2 g (w/v) graphite flakes and 2 g (w/v) NaNO~3~ were added to 90 mL of concentrated H~2~SO~4~ (98%) and mixed under constant stirring for 4 hours at 4°C. Next, 12 g (w/v) of potassium permanganate was added to the homogeneous solution under stirring conditions. Then, 184 mL of water was slowly added to this mixture and stirred for 2 hours at 4°C. The mixture was further stirred at 35°C for an additional 2 hours, followed by refluxing at 98°C for 10 minutes. The temperature of the system was shifted to 25°C and maintained for an additional 2 hours. Then, 40 mL of hydrogen peroxide solution was added in drops to the concentrated mixture, which resulted in a color change to bright yellow. A total of 400 mL of water was added to the mixture and stirred for 5 hours. GO particles were obtained by centrifugation, and were then washed with 10% HCl and deionized water several times. The collected product was freeze-dried overnight to obtain GO powder. The GO powder was dissolved in 0.1 mol/L of hydrochloric acid solution.

Physiochemical characterization of GO
-------------------------------------

The morphology of the GO samples was visualized by atomic force microscopy (AFM) (MultiMode; Veeco, New York, NY, USA) and transmission electron microscopy (TEM) (JEM-2100F; JEOL, Tokyo, Japan). Fourier-transform infrared (FTIR) spectrum was applied to identify the presence of functional groups on the surface of GO samples. The spectrum was taken from 4,000 to 400 cm^−1^ on a LabRAM HR Evolution instrument (Horiba Jobin Yvon, Palaiseau, France). GO samples were also analyzed by confocal micro-Raman spectroscopy, as described previously.

Viability of RAW 264.7 cells cultured in the presence of GO
-----------------------------------------------------------

The murine-derived macrophage cell line RAW 264.7 cells were purchase from American Type Culture Collection (ATCC). RAW 264.7 cells were cultured in 96-well plates (10^3^ cells/well) and treated with 0.1, 1, and 10 μg/mL GO in α-minimum essential medium (α-MEM) for 1 and 2 days. Cell proliferation was measured using a cell counting kit-8 assay (CCK-8; Dojindo, Kumamoto, Japan) and MTT (3-(4,5-dimethyl)thiazol-2-yl-2,5-dimethyltetrazolium bromide) following the manufacturer's instructions. For CCK-8 assay, the medium was replaced with 100 μL of α-MEM and 10 μL of CCK-8 at each time point. After a 4-hour incubation at 37°C, the absorbance at 450 nm was determined using a model 680 microplate reader (Bio-Rad Laboratories Inc., Hercules, CA, USA). As for MTT, the medium was replaced with 200 μL MTT solution (5 mg/mL) at each time point. The cells were cultured for another 5 hours. During this period, viable cells could reduce the MTT to formazan pigment, which was dissolved by 800 μL dimethyl sulfoxide (DMSO) after removal of the culture medium. The absorbance at 490 nm was recorded using a model 680 microplate reader (Bio-Rad Laboratories Inc.).

Intracellular localization of GO in RAW 264.7 cells
---------------------------------------------------

RAW 264.7 cells were seeded in a 6-well plate at a density of 10^5^ cells/well. After 24 hours of incubation, the culture medium was replaced with 2 mL of α-MEM (with 10% FBS) containing 1 μg/mL GO. After a 24-hour incubation period, the media was removed and the cells were collected into a 1.5-mL EP tube. The collected cells were washed three times with PBS and then pre-fixed with 4% glutaraldehyde at 4°C overnight. After washing with 0.1 M PBS, 1% osmium tetraoxide was applied for 1 hour to post-fix the cells. The cells were then stained with 1% uranyl acetate for 1 hour and dehydrated with a series of ethanol concentrations. Then, the cells were treated with a series of Spurr's resin concentrations, infiltrated in Spurr's resin at 70°C for 24 hours, and sectioned with an ultramicrotome. The sections were observed by TEM (HT7700; Hitachi, Tokyo, Japan).

Inflammatory response of macrophages cultured in the presence of GO
-------------------------------------------------------------------

Macrophage RAW 264.7 cells were seeded in a 6-well plate at a density of 1.5×10^5^ cells/well. After a 24-hour incubation, the culture medium was replaced with 1.5 mL of α-MEM (with 10% FBS) containing 1 μg/mL GO. After incubating for another day, the supernatant was collected by centrifugation at 3,000 rpm for 10 minutes. The collected supernatant was used as conditioned medium for growing BMSCs and HUVECs. Total RNA was isolated using an RNAiso reagent (TaKaRa Bio Inc., Shiga, Japan). Reverse transcription was performed using 2 μg of total RNA, Prime ScriptRT kit reagents, and gDNA Eraser (TaKaRa Bio Inc.). The levels of mRNAs encoding inflammatory cytokines (IL-6, IL-1β, interferon \[INF\]-γ, oncostatin M \[OSM\], TNF-α, inducible nitric oxide synthase \[iNOS\], IL-10, and arginase), Toll-like receptor (TLR) signaling pathway proteins (MyD88, TICAM-1, TICAM-2, and IκB), osteogenic cytokines (bone morphogenetic protein-2 \[BMP2\], OSM, and TGFβ), and angiogenic cytokines (VEGF) were determined using a StepOnePlus real-time PCR system (Thermo Fisher Scientific, Waltham, MA, USA) and SYBR Premix Ex Taq (TaKaRa Bio Inc.) under the following conditions: 95°C for 30 seconds followed by 40 cycles of 95°C for 5 seconds and 60°C for 30 seconds. Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) served as an internal control and allowed for differences among samples to be adjusted. DNA concentrations were calculated using the 2^−∆∆Ct^ method. All primers used in this experiment were synthesized by Sangon Biotech (Shanghai, China) and are listed in [Table 1](#t1-ijn-13-5799){ref-type="table"}.

Osteogenic gene/protein expression and mineralization of BMSCs by the stimulation of GO/RAW 264.7 cells grown in conditioned culture medium
-------------------------------------------------------------------------------------------------------------------------------------------

The BMSCs used in our study were obtained from patients with femoral fracture. All donors were given written informed consent prior to the collection of their bone marrow and the bone marrow was collected during the process of femoral fracture fixation using reamed intramedullary nailing. All protocols were approved by the Ethics board of the Second Affiliated Hospital, Zhejiang University School of Medicine. To investigate the effect of GO-stimulated macrophages on the osteogenic differentiation of BMSCs, we collected the culture supernatant from RAW 264.7 cells to use as conditioned medium for further culture. BMSCs were seeded into 6-well plates (4×10^4^ cells/well) containing osteogenic conditioned induction medium (OIM: RAW 264.7 cells conditioned medium \[with or without 1 μg/mL GO-stimulated\], 100 nM dexamethasone, 0.2 mM ascorbic acid, and 10 mM β-glycerophosphate). Total RNA was isolated from cells cultured for 3 days using the RNAiso reagent (TaKaRa Bio Inc.). Reverse transcription was performed using 2 μg of total RNA, Prime ScriptRT kit reagents, and gDNA Eraser (TaKaRa Bio Inc.). The levels of mRNAs encoding ALP, osteocalcin (OCN), runt-related transcription factor 2 (RUNX2), osteopontin (OPN), osterix, and collagen α1 type I (COL1A1) were determined using a StepOnePlus real-time PCR system (Applied Biosystems Inc.) and the SYBR Premix Ex Taq (TaKaRa Bio Inc.) under the following conditions: 95°C for 30 seconds followed by 40 cycles of 95°C for 5 seconds and 60°C for 30 seconds. GAPDH served as an internal control and allowed for differences among samples to be adjusted. DNA concentrations were calculated using the 2^−∆∆Ct^ method (Livak and Schmittgen, 2001).[@b36-ijn-13-5799] All primers used in this experiment were synthesized by Sangon Biotech and are listed in [Table 1](#t1-ijn-13-5799){ref-type="table"}.

Cells were lysed in RIPA lysis buffer (Beyotime, Shanghai, China) and subjected to SDS-PAGE on 10% polyacrylamide gels. The proteins were blotted onto poly (vinylidene fluoride) (PVDF) membranes (Millipore, Billerica, MA, USA). After blocking in 5% non-fat milk for 2 hours, the membranes were incubated overnight at 4°C with antibodies specific for GAPDH (1:1,500; Cell Signaling Technology, Danvers, MA, USA), RUNX2 (1:1,600; Cell Signaling Technology), or COL1A1 (1:5,000; Abcam, Cambridge, UK), and then incubated with horseradish-peroxidase-conjugated goat anti-rabbit IgG (1:5,000; Beyotime) (the secondary antibody) for 2 hours at room temperature. Immunoreactive bands were detected using an enhanced chemiluminescence detection reagent (Millipore) and further visualized by exposing the blots to X-ray film (Bio-Rad Laboratories Inc.) for 0.1--2 minute. Protein expression was quantified by measuring the ratio of the absorbance of the protein of interest to that of the internal control (GAPDH).

To investigate mineral deposition, Alizarin red S (ARS) (Cyagen Biosciences, Guangzhou, China) was used. BMSCs were seeded in 12-well plates in GO/RAW 264.7-conditioned osteogenic medium. After 10 days of culture, BMSCs were fixed in 4% paraformaldehyde (Sangon Biotech) for 10 minutes at room temperature, washed with distilled water, treated with ARS (0.5%) for 30 minutes at room temperature, and rinsed with distilled water. The absorbances at 560 nm of 200-μL suspensions of stained cells in 96-well plates were measured using a microplate reader (ELX808; BioTek, Winooski, VT, USA). The readings were normalized to the total protein concentrations.

To investigate mineral deposition, the ALP stain (Beyotime) was used. After 3 days of culture, cells were fixed with 4% paraformaldehyde, washed twice with PBS, and stained using the BCIP/NBT Alkaline Phosphatase Color Development Kit (Beyotime). For measurement of ALP activity, cells were lysed with lysis buffer consisting of 20 mM Tris-HCl (pH 7.5), 150 mM NaCl, and 1% Triton X-100. ALP activity was determined using the ALP Activity Assay (Beyotime) according to the manufacturer's instructions.

Signal pathways of BMSCs involved in the immunomodulatory properties of GO
--------------------------------------------------------------------------

To investigate the possible mechanisms underlying the immunomodulatory properties of GO in the osteogenesis of BMSCs, the expression levels of COL1A1, p-β-Catenin, nuclear factor-κB (NF-κB), p-Smad1/5/9, and VEGF were analyzed by Western blot. As described in the previous section, BMSCs were treated with OIM (10% FBS, 100 nM dexamethasone, 0.2 mM ascorbic acid, and 10 mM β-glycerophosphate) for 3 days.

Angiogenesis of HUVECs by stimulation with GO/RAW 264.7-conditioned culture medium
----------------------------------------------------------------------------------

To investigate the effect of GO-stimulated macrophages on the angiogenic differentiation of HUVECs, we collected the culture supernatant from the growth of RAW 264.7 cells as conditioned medium for further culture. HUVECs were purchased from ScienCell Research Laboratories (Carlsbad, CA, USA). HUVECs were seeded into 6-well plates (10^5^ cells/well) and cultured with GO-conditioned medium for 3 days. Then, angiogenic genes including CD31, MMP9, and VEGF pathway-related factor genes (VEGFR1, VEGF2, PDGFRα, and PDGFRβ) were analyzed by RT-PCR.

To investigate the angiogenic effects of GO-conditioned medium on HUVECs, we performed a tube formation assay. Briefly, 10^5^ HUVECs were seeded into 24-well plates pre-coated with Matrigel (Geltrex; Thermo Fisher Scientific, Waltham, MA, USA) and incubated with GO/RAW 264.7-conditioned medium or normal culture medium. Images were taken after 8 hours of incubation. The number of bifurcations per field was quantified by ImageJ software.

Statistical analysis
--------------------

Statistical analysis was performed using SPSS software (ver. 17.0; SPSS Inc., Chicago, IL, USA). Statistical significance was evaluated using the non-parametric Mann--Whitney and Wilcoxon signed-rank tests. All data are presented as means ± SD. A *P*-value ≤0.05 was considered to indicate statistical significance.

Results
=======

Fabrication and characterization of GO
--------------------------------------

GO nanocomposites were characterized by AFM, X-ray diffraction (XRD), TEM, and Raman spectroscopy ([Figure 1](#f1-ijn-13-5799){ref-type="fig"}). The morphology of GO nanosheets following ultrasonic treatment was observed by AFM and TEM ([Figure 1](#f1-ijn-13-5799){ref-type="fig"}). The GO nanosheets had 2D irregularly shaped flakes with diameters under 500 nm. The XRD spectra of GO showed a sharp peak at 2θ=10.84°, which was due to the oxidation of graphite ([Figure 1](#f1-ijn-13-5799){ref-type="fig"}). The Raman spectra of GO also showed two intense and prominent peaks, indicating the G band and D band ([Figure 1](#f1-ijn-13-5799){ref-type="fig"}). These two bands arose from the sp[@b2-ijn-13-5799] carbon vibrations at 1,580 and 1,345 cm^−1^. The D and G band peaks represented the defects in the GO sample and were characteristic of the breathing mode of aromatic rings.

Viability and internalization of RAW 264.7 cells cultured with GO
-----------------------------------------------------------------

To evaluate the immune modulatory properties of GO, RAW 264.7 cells were chosen for in vitro study. A CCK-8 assay was performed to study the effects of GO on the viability of RAW cells at days 1 and 2. Our results showed that GO had no toxicity to macrophages. Furthermore, low concentrations of GO could stimulate macrophage proliferation ([Figure 2](#f2-ijn-13-5799){ref-type="fig"}). The MTT showed similar results ([Figure S1](#SD1-ijn-13-5799){ref-type="supplementary-material"}).

To understand the mechanisms underlying the immuno-modulatory properties of GO, GO intracellular localization was assessed by TEM. TEM revealed a large uptake of GO by the cells when cultured with 1 μg/mL GO ([Figure 3](#f3-ijn-13-5799){ref-type="fig"}). [Figure 3A](#f3-ijn-13-5799){ref-type="fig"} shows that the GO sheets were located inside cells. [Figure 3B](#f3-ijn-13-5799){ref-type="fig"} shows that the GO sheets were phagocytosed by phagosomes within the cytosol.

Inflammatory gene expression of RAW cells cultured with GO
----------------------------------------------------------

To investigate the immune modulatory properties of GO, RAW 264.7 cells were cultured with or without GO. The gene expression results showed that the pro-inflammatory cytokines IL-6, IL-1β, INF-γ, OSM, and TNF-α were increased. However, the level of the anti-inflammatory cytokine IL-10 did not change significantly ([Figure 4](#f4-ijn-13-5799){ref-type="fig"}).

GO/RAW 264.7-conditioned culture medium promotes osteogenic differentiation of BMSCs
------------------------------------------------------------------------------------

The expression of osteogenesis-related genes in GO/RAW 264.7-conditioned culture medium was assessed by RT-PCR. The results showed that the *Runx2*, *Col1a1*, *Ocn*, *Opn*, and *Osterix* genes were significantly upregulated by conditioned medium from RAW 264.7 cells exposed to GO compared to the control groups ([Figure 5A](#f5-ijn-13-5799){ref-type="fig"}). The Western blot showed that osteogenic-related proteins, including Runx2 and Col1A1, were significantly upregulated ([Figure 5B and C](#f5-ijn-13-5799){ref-type="fig"}). ALP activity and staining revealed higher ALP activity in BMSCs treated with conditioned medium from RAW 264.7 cells exposed to GO relative to the control group ([Figure 5D and E](#f5-ijn-13-5799){ref-type="fig"}). ARS staining, which is used to determine the amount of calcium deposits, showed similar results ([Figure 5F and G](#f5-ijn-13-5799){ref-type="fig"}).

GO/RAW 264.7-conditioned culture medium promotes osteogenic differentiation of BMSCs through signaling pathways
---------------------------------------------------------------------------------------------------------------

To explore the possible mechanisms of how GO/RAW 264.7 conditioned culture medium promote the osteogenesis of MSCs, we performed RT-PCR and Western blot analysis on RAW 264.7 cells cultured with or without GO. The results showed that the expression levels of MyD 88, BMP2, VEGF, and OSM were significantly upregulated in RAW 264.7 cells stimulated with GO. The Western blot results showed that the expression levels of p-STAT3, p-β-Catenin, p-NF-κB, Smad1/5/9, and VEGF were significantly upregulated in BMSCs by GO-conditioned medium ([Figure 6](#f6-ijn-13-5799){ref-type="fig"}).

The angiogenic effect of GO via immune modulation
-------------------------------------------------

To investigate the angiogenic effect of GO via immune modulation, the expression of VEGF from RAW 264.7 cells was assessed. Our results showed that GO enhanced VEGF expression from RAW 264.7 cells. The ELISA results further confirmed the levels of VEGF in conditioned medium raised with the GO concentrations ([Figure 7A](#f7-ijn-13-5799){ref-type="fig"}). Then, we applied the GO/RAW 264.7-conditioned medium for HUVEC culture. The expression levels of angiogenic factors, including CD31 and MMP9, were upregulated by GO/RAW 264.7-conditioned medium stimulation. The expression levels of VEGF pathway-related factors, including VEGFR1, VEGF2, PDGFRα, and PDGFRβ, were increased ([Figure 7B](#f7-ijn-13-5799){ref-type="fig"}).

The endothelial tube formation assay is a classic in vitro angiogenesis test. Our results showed that HUVECs cultured in GO-conditioned medium had significantly enhanced tube formation after 8 hours of culture compared to the control group ([Figure 7C--E](#f7-ijn-13-5799){ref-type="fig"}).

Discussion
==========

In this study, we found that low concentrations of GO stimulated the proliferation of RAW 264.7 cells. RAW 264.7 cells internalized GO by phagocytosis and were stimulated to undergo a M1 phenotype switch. The RAW 264.7 cells initiated the expression of several pro-inflammatory cytokines and created a favorable immune environment for osteogenesis and angiogenesis. The immune microenvironment induced by GO could stimulate osteogenic differentiation of BMSCs through OSM and NF-κB pathways. Furthermore, it stimulated the angiogenesis of HUVECs through the VEGF pathway, which is also important for bone regeneration. The possible mechanisms of osteoimmunomodulatory effects of the GO-mediating osteogenesis and angiogenesis are summarized in [Figure 8](#f8-ijn-13-5799){ref-type="fig"}.

Macrophages are the first-line defense against foreign bodies and play a central role in the innate immune response. Several studies have shown that biomaterials, including β-tricalcium phosphate, silica, and GO, can stimulate the immune response of macrophages after implantation.[@b18-ijn-13-5799]--[@b20-ijn-13-5799] In our study, the GO sheets distributed around the RAW 264.7 cells or were up-taken and internalized by RAW 264.7 cells in the cell matrix, as shown in the TEM image of [Figure 3](#f3-ijn-13-5799){ref-type="fig"}. The results in [Figure 4](#f4-ijn-13-5799){ref-type="fig"} showed that GO stimulated RAW 264.7 cells to undergo an M1 phenotype switch, producing IL-6, IL-1β, INF-γ, OSM, and TNF-α. Our results showed that the surface makers CD11c and CC7 of M1 were significantly upregulated in RAW 264.7 cells treated with GO. This was consistent with the literature.[@b16-ijn-13-5799] According to the results in [Figure 6](#f6-ijn-13-5799){ref-type="fig"}, MyD88 and TICAM-2 were significantly upregulated in the GO group. Therefore, we speculated that GO stimulated RAW 264.7 cells through the NF-κB signal pathway, which led to the activation of downstream cascades. Chen et al[@b21-ijn-13-5799] reported that the regulation of phagocytosis by TLRs was mediated by direct interaction with MyD88.

We found that the immune microenvironment modulated by GO could stimulate osteogenic differentiation of BMSCs. As shown in [Figure 5](#f5-ijn-13-5799){ref-type="fig"}, GO could not only stimulate early osteogenic gene expression, but also calcium deposition. This may be mediated by OSM and BMP2, which are secreted by RAW 264.7 cells. Generally, macrophages are divided into two phenotypes: classically activated inflammatory macrophages (M1) and alternatively activated inflammatory macrophages (M2). Traditionally, the M1 phenotype is known to elicit proinflammatory effects, which may cause bone resorption, while the M2 phenotype is associated with osteogenesis.[@b22-ijn-13-5799] However, in recent years, some studies have reported that the M1 phenotype is beneficial for osteogenesis through the activation of the OSM signaling pathway.[@b23-ijn-13-5799],[@b24-ijn-13-5799] Our results showed that the expression levels of OSM and BMP2 in RAW 264.7 cells in the GO group were significantly upregulated. The Western blot results showed that the expression levels of p-STAT3 and Smad1/5/9 were significantly upregulated. Several studies have reported that OSM can activate osteogenesis through activation of STAT3.[@b25-ijn-13-5799],[@b26-ijn-13-5799] In addition, BMP2 is a well-known growth factor that promotes osteogenesis, and has been used in clinical applications.[@b27-ijn-13-5799] BMP2 promotes osteogenic differentiation mainly through the Smad1/5/9 signal pathway.[@b28-ijn-13-5799] These results show that GO stimulates the formation of an immune microenvironment that is favorable for BMSC osteogenesis.

TNF-α has been shown to have dual effects on the osteogenic differentiation of BMSCs: it promotes osteogenic differentiation at low concentrations and inhibits osteogenic differentiation at high concentrations (\>10 ng/mL).[@b29-ijn-13-5799] Our results showed that GO stimulated RAW 264.7 cells to secrete very low concentrations (\<1 ng/mL) of TNF-α. Therefore, the range of concentrations of TNF-α in this immunomodulatory environment favors osteogenic differentiation of BMSCs.

Our results showed that the immune microenvironment modulated by GO could stimulate angiogenic differentiation of HUVECs. Angiogenesis is also important for bone tissue engineering.[@b30-ijn-13-5799],[@b31-ijn-13-5799] After tissue engineering, bone is implanted in vivo. A major challenge in the clinical evolution of bone substitutes is the maintenance of cell viability in the graft center, which mainly depends on the rapidity of host blood vessel invasion.[@b30-ijn-13-5799] Some researchers tried to combine osteogenic and angiogenic growth factors for bone regeneration;[@b32-ijn-13-5799],[@b33-ijn-13-5799] however, the high costs of the growth factors limited further clinical applications. In our study, we showed GO could not only promote osteogenesis of BMSCs, but also stimulate angiogenesis of HUVECs. Our results indicate that GO-stimulated angiogenesis may activate downstream signaling pathways through VEGFR and PDGFR, resulting in the proliferation and angiogenesis of vascular ECs. A number of studies have shown that a combination of VEGFR and PDGFR with corresponding ligands can promote the proliferation and angiogenesis of vascular ECs by activating multiple signaling pathways, such as PI3K/Akt, MAPK, and PLC-γ.[@b34-ijn-13-5799],[@b35-ijn-13-5799] Therefore, GO can be used to stimulate the development of an immune microenvironment that is suitable for bone regeneration.

Conclusion
==========

In conclusion, this study shows that the immune microenvironment induced by GO stimulates osteogenic differentiation of BMSCs through the OSM and NF-κB pathways, and angiogenesis of HUVECs through the VEGF pathway. Since both osteogenesis and angiogenesis are important for bone regeneration, GO may be used as an immunomodulatory agent for bone tissue engineering applications.

Supplementary material
======================

###### 

The effect of GO on the proliferation of RAW 264.7 cells (\**P*\<0.05 versus 0 μg/mL, day 1 and ^\#^*P*\<0.05 versus 0 μg/mL, day 2).

**Abbreviation:** GO, graphene oxide.
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![(**A**) Representative two-dimensional AFM image of GO; (**B**) XRD pattern of GO; (**C**) TEM image of GO; and (**D**) Raman spectra of GO.\
**Abbreviations:** GO, graphene oxide; AFM, atomic force microscopy; XRD, X-ray diffraction; TEM, transmission electron microscopy.](ijn-13-5799Fig1){#f1-ijn-13-5799}

![The effect of GO on the proliferation of RAW 264.7 cells (\**P*\<0.05 versus 0 μg/mL, day 1 and ^\#^*P*\<0.05 versus 0 μg/mL, day 2).\
**Abbreviation:** GO, graphene oxide.](ijn-13-5799Fig2){#f2-ijn-13-5799}

![TEM images of GO sheets internalized by macrophages. (**A**) Blue arrows indicate GO sheets within the cytosol. (**B**) Green arrows indicate GO sheets phagocytosed by phagosomes; and the red arrow indicates GO sheets around the cells.\
**Abbreviations:** GO, graphene oxide; TEM, transmission electron microscopy.](ijn-13-5799Fig3){#f3-ijn-13-5799}

![Inflammatory response of macrophages cultured with GO conditioned medium. RT-PCR showed that gene expression was increased. \**P*\<0.05 versus the control group.\
**Abbreviations:** GO, graphene oxide; IL, interleukin; INF-γ, interferon gamma; iNOS, inducible nitric oxide synthase; OSM, oncostatin M; TNF-α, tumor necrosis factor alpha; RT-PCR, reverse transcriptase-polymer chain reaction.](ijn-13-5799Fig4){#f4-ijn-13-5799}

![Osteogenic differentiation of BMSCs by stimulation with GO/RAW 264.7 conditioned culture medium.\
**Notes:** (**A**) The expression levels of osteogenic mRNAs were determined by qPCR under conditions of osteogenic differentiation. (**B** and **C**) Western blotting analysis after osteogenic differentiation was used to determine the expression of Runx2 and Col1A1 proteins. (**D**) ALP in BMSCs was stained after osteogenic differentiation for 3 days. (**E**) ALP activity of BMSCs. (**F**) ARS staining after osteogenic differentiation for 9 days. (**G**) Mineralization was quantified by extracting ARS-stained cells. All data were confirmed by three repeated tests. \**P*\<0.05 versus the control group.\
**Abbreviations:** ALP, alkaline phosphatase; ARS, Alizarin red S; BMSCs, bone marrow stem cells; COL1A1, collagen α1 type I; GAPDH, glyceraldehyde 3-phosphate dehydrogenase; GO, graphene oxide; OCN, osteocalcin; OPN, osteopontin; qPCR, quantitative PCR; RUNX2, runt-related transcription factor 2.](ijn-13-5799Fig5){#f5-ijn-13-5799}

![(**A**) Relative mRNA expression levels of MyD88, TICAM-1, TICAM-2, BMP2, TGFβ, IκB, VEGF, and OSM from RAW 264.7 cells cultured in the presence of GO. (**B**, **C**) Western blot analysis of COL1A1, p-β-Catenin, p-NF-κB and Smad1/5/9 expression by BMSCs cultured in osteogenic medium and GO/RAW 264.7 conditioned osteogenic culture medium. \**P*\<0.05 versus the control group.\
**Abbreviations:** BMSCs, bone marrow stem cells; BMP2, bone morphogenetic protein-2; OSM, oncostatin M; TGFβ, transforming growth factor β, VEGF, vascular endothelial growth factor.](ijn-13-5799Fig6){#f6-ijn-13-5799}

![Angiogenic differentiation of HUVECs by stimulation with GO/RAW 264.7 conditioned medium.\
**Notes:** (**A**) ELISA results showed that the levels of VEGF in condition medium raised with the GO concentrations. A tube formation assay was performed with normal culture medium. (**B**) RT-PCR showed that gene expression levels of angiogenic factors and VEGF pathway-related factors were increased compared to the control group (\**P*\<0.05) (**C**) and GO/RAW 264.7 (**D**) conditioned medium for 8 hours. (**E**) Bifurcations numbers of the tubes.\
**Abbreviations:** GO, graphene oxide; HUVECs, human umbilical vein endothelial cells; RT-PCR, reverse transcriptase-polymer chain reaction; VEGF, vascular endothelial growth factor.](ijn-13-5799Fig7){#f7-ijn-13-5799}

![The possible mechanisms of osteoimmunomodulatory effects of the GO mediating osteogenesis and angiogenesis.\
**Abbreviations:** BMP2, bone morphogenetic protein-2; GO, graphene oxide; HUVEC, human umbilical vein endothelial cell; IL, interleukin; MSC, mesenchymal stem cell; NF-κB, nuclear factor-κB; OSM, oncostatin M; TGFβ, transforming growth factor β; VEGF, vascular endothelial growth factor.](ijn-13-5799Fig8){#f8-ijn-13-5799}

###### 

Primer sequences for real-time quantitative PCR

  Genes      Gene bank number   Forward primer           Reverse primer              Product size
  ---------- ------------------ ------------------------ --------------------------- --------------
  GAPDH      DQ403057.1         CTCAGTTGCTGAGGAGTCCC     ATTCGAGAGAAGGGAGGGCT        60
  IL-6       BC138766.1         GACAAAGCCAGAGTCCTTCAGA   TGTGACTCCAGCTTATCTCTTGG     99
  IL-1β      NM_008361.4        GCCACCTTTTGACAGTGATGAG   GACAGCCCAGGTCAAAGGTT        95
  INF-γ      NM_008337.4        CAGCAACAGCAAGGCGAAAA     TCATTGAATGCTTGGCGCTG        90
  TNF-α      AY423855.1         GATCGGTCCCCAAAGGGATG     ACTGATGAGAGGGAGGCCAT        86
  iNOS       U43428.1           GAGCCACAGTCCTCTTTGCT     CAACCTTGGTGTTGAAGGCG        111
  IL-10      NM_010548.2        GGCCCAGAAATCAAGGAGCA     AATCGATGACAGCGCCTCAG        62
  Arginase   U51805.1           CTGCGACCCAAGAAGACTAGA    TTGAGAAAGGCGCTCCGATAA       164
  RUNX2      NM_001024630.3     CAAGTGGCCAGGTTCAACGA     TGTGAAGACCGTTATGGTCAAAGTG   77
  COL1A1     NM_000088.3        CCTGCTGGCAAGAGTGGTGAT    CAAGTTCCGGTGTGACTCGTG       145
  OCN        NM_199173.5        AGGACCCTCTCTCTGCTCAC     GCTCACACACCTCCCT            68
  OPN        J04765.1           GACGAGCACATCACCTCACA     GGCTTCAGCACTCTGGTCAT        58
  Osterix    AF477981.1         GCTCCTTGGGACCCGTTC       GAGTTGTTGAGTCCCGCAGA        112
  MyD88      U70451.1           CATACCCTTGGTCGCGCTTA     TCCGAGGGTTCAAGAACAGC        115
  TICAM1     NM_182919.3        CTTCCCCACAGTCCCAATCC     GAACCATCTGGGCATGGTGA        66
  TICAM2     NM_021649.7        TTGCTCAGTGCGAGAGGAAG     GTGGTACTGCTTGACCACGA        165
  TGFβ1      NM_001036.4        GTCACTGGAGTTGTACGGCA     AGCCCTGTATTCCGTCTCCT        73
  BMP2       NM_001200.3        TGCTTCTTAGACGGACTGCG     CACTAGAAGACAGCGGGTCC        66
  OSM        NM_020530.5        TCATCCTGAGCATGGCACTG     CGTGAGGTTCGCCTGATTCT        63
  VEGF       AY047581.1         AACGATGAAGCCCTGGAGTG     GCTGGCTTTGGTGAGGTTTG        117
  CD31       NM_000442.4        GACTGAACCTGTCCTGCTCC     GGATGGTGAAGTTGGCTGGA        70
  MMP9       NM_004994.2        AAATCCCCACTGGGACCAAC     TTGTATCCGGCAAACTGGCT        92
  VEGFR1     EU826562.1         TGCCTGTGGAAGAAATGGCA     GCTGTAGAAGCCAGTGTGGT        92
  VEGFR2     EU826563.1         CGGAAATGACACTGGAGCCT     AATGACCGAGGCCAAGTCAG        61
  PDGFRα     NM_006206.5        TGCGTAAGAGCAAAAAGCGA     GCTCCGAATCTCCCAGTGTC        57
  PDGFRβ     NM_002609.3        GGATCGCTCTGTGAGCAACT     GGCTCTCTCCTCCTCCTTGT        102

[^1]: These authors contributed equally to this work
